# Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome

> **NCT00002547** · PHASE2 · COMPLETED · sponsor: **Barbara Ann Karmanos Cancer Institute** · enrollment: 280 (actual)

## Conditions studied

- Leukemia
- Myelodysplastic Syndromes

## Interventions

- **DRUG:** busulfan
- **DRUG:** cyclophosphamide
- **DRUG:** cyclosporine
- **DRUG:** cytarabine
- **DRUG:** methotrexate
- **PROCEDURE:** allogeneic bone marrow transplantation
- **PROCEDURE:** syngeneic bone marrow transplantation

## Key facts

- **NCT ID:** NCT00002547
- **Lead sponsor:** Barbara Ann Karmanos Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1987-08
- **Primary completion:** 2003-10
- **Final completion:** 2003-10
- **Target enrollment:** 280 (ACTUAL)
- **Last updated:** 2012-08-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002547, "Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00002547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*